SV40-positive brain tumor in scientist with risk of laboratory exposure to the virus

Oncogene

Volumn 23, Issue 12, 2004, Pages 2231-2235

  Arrington, Amy S ^a   Moore, Mary Shannon ^a   Butel, Janet S ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Brain tumor; Meningioma; Simian virus 40

Indexed keywords

DNA; DIAGNOSTIC AGENT; GADOLINIUM; VIRUS T ANTIGEN;

ARTICLE; BRAIN CANCER; BRAIN TUMOR; CANCER RISK; CONTROLLED STUDY; DISEASE COURSE; DNA SEQUENCE; DNA TUMOR VIRUS; HUMAN; LABORATORY TEST; MEDICAL RESEARCH; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SIMIAN VIRUS 40; VIRUS DETECTION; ADULT; CASE REPORT; CEREBROSPINAL FLUID; FEMALE; GENETIC POLYMORPHISM; GENETICS; HOSPITAL LABORATORY; IMMUNOLOGY; LABORATORY PERSONNEL; MENINGIOMA; NON-PROGRAMMATIC; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; POLYMERASE CHAIN REACTION; RISK FACTOR; TREATMENT OUTCOME; TUMOR CELL LINE; UNITED STATES; VIROLOGY; VIRUS INFECTION;

ANIMALIA; DNA VIRUSES; PAPOVAVIRIDAE; SIMIAE; SIMIAN VIRUS 40;

NON-PROGRAMMATIC;

ADULT; ANTIGENS, POLYOMAVIRUS TRANSFORMING; BRAIN NEOPLASMS; CELL LINE, TUMOR; FEMALE; GADOLINIUM; HUMANS; LABORATORIES, HOSPITAL; LABORATORY PERSONNEL; MAGNETIC RESONANCE IMAGING; MENINGIOMA; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYOMAVIRUS INFECTIONS; RISK FACTORS; SEQUENCE ANALYSIS, DNA; SIMIAN VIRUS 40; TEXAS; TREATMENT OUTCOME; TUMOR VIRUS INFECTIONS;

EID: 1842538760     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207341     Document Type: Article

References (37)

1. Arrington AS and Butel JS. (2001). Human Polyomaviruses: Molecular and Clinical Perspectives, Khalili K and Stoner GL (ed). John Wiley & Sons: New York, pp. 461-489.
2. Arrington AS, Lednicky JA and Butel JS. (2000). Anticancer Res., 20, 879-884.
3. Bocchetta M, Di Resta I, Powers A, Fresco R, Tosolini A, Testa JR, Pass HI, Rizzo P and Carbone M. (2000). Proc. Natl. Acad. Sci. USA, 97, 10214-10219.
4. Brinster RL, Chen HY, Messing A, Van Dyke T, Levine AJ and Palmiter RD. (1984). Cell, 37, 367-379.
5. Butel JS. (2000). Carcinogenesis, 21, 405-426.
6. Butel JS, Arrington AS, Wong C, Lednicky JA and Finegold MJ. (1999). J. Infect. Dis., 180, 884-887.
7. Butel JS and Lednicky JA. (1999). J. Natl. Cancer Inst., 91, 119-134.
8. Butel JS and Ozbun MA. (1994). Methods in Molecular Genetics. Vol. 4: Molecular Virology Techniques, Part A, Adolph KW (ed). Academic Press: San Diego, pp. 282-309.
9. David H, Mendoza S, Konishi T and Miller CW. (2001). Cancer Lett., 162, 57-64.
10. Eddy BE, Borman GS, Grubbs GE and Young RD. (1962). Virology, 17, 65-75.
11. Evans AS and Mueller NE. (1990). Ann. Epidemiol., 1, 71-92.
12. Gazdar AF, Butel JS and Carbone M. (2002). Nat. Rev. Cancer, 2, 957-964.
13. Gerber P and Kirschstein RL. (1962). Virology, 18, 582-588.
14. Gish WR and Botchan MR. (1987). J. Virol., 61, 2864-2876.
15. Griffiths DJ, Nicholson AG and Weiss RA. (1998). Dev. Biol. Stand., 94, 127-136.
16. Huang KC, Yamasaki EF and Snapka RM. (1999). Virology, 262, 457-469.
17. Hwang SP and Kucherlapati R. (1980). Virology, 105, 196-204.
18. Ilyinskii PO, Daniel MD, Horvath CJ and Desrosiers RC. (1992). J. Virol., 66, 6353-6360.
19. Jasani B, Cristaudo A, Emri SA, Gazdar AF, Gibbs A, Krynska B, Miller C, Mutti L, Radu C, Tognon M and Procopio A. (2001). Semin. Cancer Biol., 11, 49-61.
20. Krieg P and Scherer G. (1984). Virology, 138, 336-340.
21. Lednicky JA, Arrington AS, Stewart AR, Dai XM, Wong C, Jafar S, Murphey-Corb M and Butel JS. (1998). J. Virol., 72, 3980-3990.
22. Lednicky JA and Butel JS. (1997). J. Gen. Virol., 78, 1697-1705.
23. Lednicky JA and Butel JS. (2001). Semin. Cancer Biol., 11, 39-47.
24. Lednicky JA, Garcea RL, Bergsagel DJ and Butel JS. (1995). Virology, 212, 710-717.
25. Lednicky JA, Stewart AR, Jenkins III JJ, Finegold MJ and Butel JS. (1997). Int. J. Cancer, 72, 791-800.
26. Li RM, Branton MH, Tanawattanacharoen S, Falk RA, Jennette JC and Kopp JB. (2002). J. Am. Soc. Nephrol., 13, 2320-2330.
27. Ling PD, Lednicky JA, Keitel WA, Poston DG, White ZS, Peng RS, Liu Z, Mehta SK, Pierson DL, Rooney CM, Vilchez RA, Smith EO and Butel JS. (2003). J. Infect. Dis., 187, 1571-1580.
28. Martini F, Lazzarin L, Iaccheri L, Vignocchi B, Finocchiaro G, Magnani I, Serra M, Scotlandi K, Barbanti-Brodano G and Tognon M. (2002). Cancer, 94, 1037-1048.
29. Newman JS, Baskin GB and Frisque RJ. (1998). J. Neurovirol., 4, 394-406.
30. O'Neill FJ and Carroll D. (1981). Virology, 112, 800-803.
31. O'Neill FJ, Xu X and Gao Y. (1992). Virus Res., 25, 169-187.
32. Pinkert CA, Brinster RL, Palmiter RD, Wong C and Butel JS. (1987). Virology, 160, 169-175.
33. Shein HM. (1967). J. Neuropathol. Exp. Neurol., 26, 60-76.
34. Stewart AR, Lednicky JA and Butel JS. (1998). J. Neurovirol., 4, 182-193.
35. Tavis JE, Trowbridge PW and Frisque RJ. (1994). Virology, 199, 384-392.
36. Vilchez RA, Kozinetz CA, Arrington AS, Madden CR and Butel JS. (2003). Am. J. Med., 114, 675-684.
37. Vilchez RA, Madden CR, Kozinetz CA, Halvorson SJ, White ZS, Jorgensen JL, Finch CJ and Butel JS. (2002). Lancet, 359, 817-823.